
389: Hims' Super Bowl fallout, and the FDA reverses course
The Readout Loud
00:00
Hims expanding into longevity and cancer testing
Katie outlines Hims' broader moves: peptides, multicancer detection tests, international expansion, acquisitions.
Play episode from 28:48
Transcript


